Probiota, last successful exhibition for Gnosis by Lesaffre • Lesaffre Human Care
23804
post-template-default,single,single-post,postid-23804,single-format-standard,ajax_fade,page_not_loaded,,qode_popup_menu_text_scaledown,qode-child-theme-ver-1.0.0,qode-theme-ver-13.3,qode-theme-bridge,disabled_footer_top,wpb-js-composer js-comp-ver-5.4.5,vc_responsive
 

Probiota, last successful exhibition for Gnosis by Lesaffre

Probiota, last successful exhibition for Gnosis by Lesaffre

For 13 years, the Probiota editions has tracked the evolution of pre and probiotics in a series of informative and engaging events.

Probiota 2020 in Dublin just closed its doors and offered this week three days of engaging contents, hottest topics discussions and networking opportunities with the best players in the probiotics and microbiome industries.

At Probiota, Gnosis by Lesaffre presented the poster of the clinical study demonstrating the ability of QuatrefloraTM Biotic to migrate from the intestine to the vagina after oral administration. Gnosis by Lesaffre also introduced the last published independent clinical study that confirmed the efficacy of S.cerevisiae CNCM I-3856 (ibSium®) for abdominal pain relief and bowel habits improvements.

Our roundtable session on Tuesday was a great opportunity to discuss the next challenges that will shape tomorrow’s digestive health probiotics offer: strains that target specific gut health benefits, functional foods, personalized offer… just a few examples of interesting digestive health opportunities.

We would like to thank all partners, customers and visitors who stopped at our booth to share our mutual interest on probiotics perspectives and potential future business projects and visions.

We look forward to seeing you at the next edition Probiota Americas in Washington DC (May 27 – 29, 2020).